0001217234-21-000206.txt : 20210817 0001217234-21-000206.hdr.sgml : 20210817 20210817185914 ACCESSION NUMBER: 0001217234-21-000206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210625 FILED AS OF DATE: 20210817 DATE AS OF CHANGE: 20210817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seeto Reginald CENTRAL INDEX KEY: 0001688485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36536 FILM NUMBER: 211184530 MAIL ADDRESS: STREET 1: C/O ARDELYX, INC. STREET 2: 34175 ARDENWOOD BLVD, SUITE 200 CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CareDx, Inc. CENTRAL INDEX KEY: 0001217234 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 943316839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 TOWER PLACE STREET 2: 9TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-287-2300 MAIL ADDRESS: STREET 1: 1 TOWER PLACE STREET 2: 9TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: XDx, Inc. DATE OF NAME CHANGE: 20071010 FORMER COMPANY: FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC DATE OF NAME CHANGE: 20030203 4 1 wf-form4_162924113493011.xml FORM 4 X0306 4 2021-06-25 0 0001217234 CareDx, Inc. CDNA 0001688485 Seeto Reginald C/O CAREDX, INC. 1 TOWER PLACE, 9TH FLOOR SOUTH SAN FRANCISCO CA 94080 1 1 0 0 See Remarks Common Stock 2021-06-25 4 M 0 3247 24.35 A 135618 D Common Stock 2021-06-25 4 M 0 5963 27.72 A 141581 D Common Stock 2021-06-25 4 S 0 9210 95.1485 D 132371 D Common Stock 2021-06-28 4 M 0 1545 24.35 A 133916 D Common Stock 2021-06-28 4 M 0 11667 27.17 A 145583 D Common Stock 2021-06-28 4 S 0 8522 95.4177 D 137061 D Common Stock 2021-06-28 4 S 0 4690 96.3413 D 132371 D Common Stock 2021-08-11 4 M 0 10821 27.72 A 143192 D Employee Stock Option (right to buy) 24.35 2021-06-25 4 M 0 3247 0 D 2030-02-03 Common Stock 3247.0 31961 D Employee Stock Option (right to buy) 27.72 2021-06-25 4 M 0 5963 0 D 2028-11-26 Common Stock 5963.0 66869 D Employee Stock Option (right to buy) 24.35 2021-06-28 4 M 0 1545 0 D 2030-02-03 Common Stock 1545.0 30416 D Employee Stock Option (right to buy) 27.17 2021-06-28 4 M 0 11667 0 D 2029-02-04 Common Stock 11667.0 14500 D Employee Stock Option (right to buy) 27.72 2021-08-11 4 M 0 10821 0 D 2028-11-26 Common Stock 10821.0 56048 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $90.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $96.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.10 to $96.53, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. 25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. President & Chief Executive Officer /s/ Reginald Seeto 2021-08-17